Hero

geneXplain GmbH

Main Industry
IT
updated 
updated 

Key Facts

This company profile is a search result of implisense.com

Products and Services

CompoundsCompositeTools

Size (Revenue & Employees)

Small company

Balance sheet total

2 M €

Purpose

Entwicklung, Pflege und Vertrieb von Software und Wissensbasen für die Systembiologie sowie Angebot und Vermarktung systembiologischer Dienstleistungen.

More? Implisense Plus!

Order Implisense Plus now for full company profiles and complete functionality! You will then have access to our GDPR-compliant real-time contact search, full annual reports, all search filters, complete search results and integrated AI analyses of the business model and management report.

  • Real-time search for contact persons
  • Complete annual reports
  • More search filters and results
Order now

Customer Relationship Intelligence: The Key to Optimizing your Sales Processes

Use our AI-powered assistants to identify the right companies, track current developments and market changes, reach relevant decision-makers and perfect your sales strategy with data-based insights. All seamlessly integrated into your CRM.

  • Find the right companies
  • Keep an eye on your target companies
  • Reach the right decision-makers
  • Increase your closing rate

Executive Summary

Implisense Assist gives you the opportunity to use AI to find out about companies via chat, analyze them and much more. We from the Implisense team also provide you with ready-made analyses, e.g., an executive summary and a financial analysis. Just try it out for yourself!

Implisense Plus
implisense assist

profile random user logo

implisense assist

Contacts

  • Alexander Kel

One authorized signatory

Show more

Timeline

Register Announcements

geneXplain GmbH 2022: Umlaufintensität erhöht sich!

Die Umlaufintensität der geneXplain GmbH hat sich um % im Vorjahresvergleich vermehrt. Die bemerkenswerte Steigerung des Umlaufvermögens um % bei einer größeren Bilanzsumme um % indiziert eine erhöhte Zahlungsfähigkeit. Der vollständige Jahresabschlussbericht für das Fiskaljahr 2022 ist jetzt einsehbar und liefert spannende Kennzahlen und Analysen.

Beginn des Förderprojektes "Verbundprojekt: Entwicklung einer neuen Antikrebs-Therapie zur Überwindung der Therapieresistenz durch Induktion des oxidativen Stresses im Tumorgewebe mittels Hemmung der Thioredoxinreduktase, Teilprojekt: Analyse der Resistenz gegen LCTA2940 und Identifizierung von Wirkstoffkombinationen zu deren Überwindung" (BMBF 01QE2216A)

Heute startet das Förderprojekt "Verbundprojekt: Entwicklung einer neuen Antikrebs-Therapie zur Überwindung der Therapieresistenz durch Induktion des oxidativen Stresses im Tumorgewebe mittels Hemmung der Thioredoxinreduktase, Teilprojekt: Analyse der Resistenz gegen LCTA2940 und Identifizierung von Wirkstoffkombinationen zu deren Überwindung". Es wird vom BMBF unter dem Förderkennzeichen 01QE2216A für die geneXplain GmbH mit einer Summe von 289.033,00 Euro gefördert. Die Laufzeit des Projektes beträgt 36 Monate.

Abschluss des Förderprojektes "Verbundprojekt: Analyse des Atemwegsmikrobioms und klinischer Daten zur Vorhersage akuter Exazerbationen der chronisch obstruktiven Lungenerkrankung (COPD), Teilprojekt: Entwicklung eines Klassifizierungsverfahrens für die COPD-Vorhersage" (BMBF 01QE1938B)

Heute endet das Förderprojekt "Verbundprojekt: Analyse des Atemwegsmikrobioms und klinischer Daten zur Vorhersage akuter Exazerbationen der chronisch obstruktiven Lungenerkrankung (COPD), Teilprojekt: Entwicklung eines Klassifizierungsverfahrens für die COPD-Vorhersage". Es wurde vom BMBF unter dem Förderkennzeichen 01QE1938B für die geneXplain GmbH mit einer Summe von 214.667,00 Euro gefördert. Die Laufzeit des Projektes betrug 36 Monate.

Abschluss des Förderprojektes "FindingMS - Ein integrierter Ansatz zur Vorhersage der Krankheitsaktivität in den frühen Phasen der Multiplen Sklerose" (BMBF 01KU1911)

Heute endet das Förderprojekt "FindingMS - Ein integrierter Ansatz zur Vorhersage der Krankheitsaktivität in den frühen Phasen der Multiplen Sklerose". Es wurde vom BMBF unter dem Förderkennzeichen 01KU1911 für die geneXplain GmbH mit einer Summe von 134.663,00 Euro gefördert. Die Laufzeit des Projektes betrug 36 Monate.

Abschluss des Förderprojektes "i:DSem - Verbundprojekt: MyPathSem - Eine Datenintegrationsplattform für die Generierung von Patienten-spezifischen Signalwegen für individualisierte Behandlungsentscheidungen in klinischen Anwendungen -Teilprojekt B" (BMBF 031L0024B)

Heute endet das Förderprojekt "i:DSem - Verbundprojekt: MyPathSem - Eine Datenintegrationsplattform für die Generierung von Patienten-spezifischen Signalwegen für individualisierte Behandlungsentscheidungen in klinischen Anwendungen -Teilprojekt B". Es wurde vom BMBF unter dem Förderkennzeichen 031L0024B für die geneXplain GmbH mit einer Summe von 202.980,00 Euro gefördert. Die Laufzeit des Projektes betrug 60 Monate.
Latest News

Search in real time for news and events – topic-specific, live, and contextual to the selected company.

Network

Discover connections between companies via managers, shareholdings, links or addresses here.

Register to see more connections via management and web links. Get access to an interactive network to better understand the environment of this company.

Show more

Products & Technologies

Compounds
Composite
Tools
Software
Proteomics
Enzyme
Genomics
Pipelines
Daten
See all 20 entries

Register for a free Implisense account to get advanced analysis and more extensive search results.

Show more

geneXplain GmbH is mentioned in public sources in the context of the following products and services. Compounds, Composite and Tools are the most common. The ranking list shown is without guarantee of completeness or correctness.

Artificial IntelligenceKünstliche Intelligenz
CRMCRM-System
Database ManagementPostgresql
ERPCOVALENT
Operation SystemsLinux
Programming LanguagesJava
SQL

The following software solutions, technologies and concepts are often referenced in job postings and press releases of geneXplain GmbH. Most frequently recognized were Künstliche Intelligenz, Java and CRM-System.

Dominance, Competence, ClarityInnovation, Passion, CreativityHarmony, Reliability, CommunicatibilityDilligence, Introspection, Thoroughness

Dominance, Competence, Clarity

Innovation, Passion, Creativity

Harmony, Reliability, Communicatibility

Dilligence, Introspection, Thoroughness

The 4 Color Scheme separates people and their personalities into four groups. geneXplain GmbH emphasizes the following character types in their external communications and job advertisements.

You can find more information on the FAQ page.

Information for Job Seekers

Based on job advertisements of geneXplain GmbH, the following specific requirements for job seekers were identified more frequently. Specific requirements can be found in the latest published job advertisements.

Persönliche Kompetenz

  • Flexibilität
  • Einsatzbereitschaft
  • Beharrlichkeit

Soziale Kompetenz

  • Emotionale Intelligenz
Register for free and try Implisense Plus!

Register quickly and easily for a free Implisense account. Registered users have access to extended company profiles and receive more comprehensive search results. If you register with a business email address, we will also set up a free 7-day trial for Implisense Plus in a timely manner.

  • Richer Company Profiles
  • Expanded Search Results
  • Personal Favourites
The company information presented on implisense.com comes from public sources and is verified and aggregated automatically. Implisense cannot guarantee the timeliness, completeness, quality, reliability or accuracy of the data. For questions or suggestions, please use the contact form.

This website uses cookies to provide this service and improve the user experience. Please select the cookies you wish to accept. You can find further information in our data protection declaration.

Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Google Analytics, which set cookies for user identification. Google Analytics is a service offered by a third party provider.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.
Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Google Analytics, which set cookies for user identification. Google Analytics is a service offered by a third party provider.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.

Save selectionSelect all